Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)

Elisa Gabanti, Roberta Sciarra, MD, Oscar Borsani, MD, Giuseppe Gerna, Daniela Caldera, MD, Anna Amelia Colombo, MD, Emilio Paolo Alessandrino, MD, Paolo Bernasconi, MD, Daniele Lilleri

Blood (2019) 134 (Supplement_1): 4544.

https://doi.org/10.1182/blood-2019-129939

Published: 2019

Journal Articles

Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation

Oscar Borsani, MD, Daniele Lilleri, Elisa Gabanti, Gabriela Cassinelli, Anna Amelia Colombo, MD, Daniela Caldera, MD, Emilio Paolo Alessandrino, MD, Paolo Bernasconi, MD

Blood (2019) 134 (Supplement_1): 5643.

https://doi.org/10.1182/blood-2019-124121

Published: 2019

Journal Articles

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Paolo Bernasconi, MD, Anna Amelia Colombo, MD, Daniela Caldera, MD, Oscar Borsani, MD

Blood (2019) 134 (Supplement_1): 5649.

https://doi.org/10.1182/blood-2019-125608

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Polycythemia Vera or Essential Thrombocythemia Transformed to Myelofibrosis or Acute Myeloid Leukemia: a Single Center Experience

Paolo Bernasconi, Anna Amelia Colombo, MD, Daniela Caldera, MD, Virginia Valeria Ferretti, Silvia Mangiacavalli, MD, Marta Ubezio, MD, Daniela Pietra, PhD, Elisa Rumi, MD, Ilaria Carola Casetti, MD, Matteo Davià, Marina Boni, Irene Dambruoso, Rita Zappatore

Blood (2017) 130 (Supplement 1): 5497.

https://doi.org/10.1182/blood.V130.Suppl_1.5497.5497

Published: 2017

Journal Articles

Can Allo-HSCT Improve the Poor Clinical Outcome of the “Internal Tandem Duplication” of the FLT3 Gene?

Paolo Bernasconi, MD, Catherine Klersy, MD, Anna Amelia Colombo, MD, Daniela Caldera, MD, Francesco Ripamonti, MD, Patrizia Zappasodi, MD, Barbara Rocca, BSc, Celeste Calvello, BSc, Matteo Giovanni Della Porta, Marianna Rossi, MD, Manuela Santantonio, MD, Irene Dambruoso, Rita Zappatore, PhD, Mirko Farina, Daniela Troletti, BSc, Marina Boni, Carlo Castagnola, MD, Emilio Paolo Alessandrino, MD

Blood (2014) 124 (21): 5938.

https://doi.org/10.1182/blood.V124.21.5938.5938

Published: 2014

Journal Articles

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Felipe Suarez, MD, Philippe Bourget, PhD, Emilio Paolo Alessandrino, MD, Mario Regazzi, PhD, Gérard Socié, MD, PhD, Mauricette Michallet, MD, PhD, Jérôme Guitton, PHD, Sebastien Wittnebel, MD, Angelo Paci, PHD, Didier Blaise, MD, Bénédicte Devictor, PHD, Ana Berceanu, MD, Véronique Kemmel, PHD, Jorge Sierra, MD, PhD, Maria Estela Moreno Martinez, PHD, Ambroise Marcais, MD, Alexandre Amin, PHD, Anna Amelia Colombo, MD, Francesco Ripamonti, MD, de Latour Régis Peffault, MD, Nathalie Dhedin, MD, Alienor Xhaard, MD, Hélène Labussière-Wallet, MD, Franck E Nicolini, MD, PhD, Marie Y. Detrait, MD, Sophie Ducastelle, MD, Xavier Thomas, MD, Jean-Henri Bourhis, MD, PhD, Gonzalo Ferrini, PHD, Sabine Furst, MD, Bruno Lioure, MD, Rodrigo Martino, MD, PhD, Mireia Riba, PH, Anna Feliu, PHD, Carole Levrault, Marcello Riggi, MD, PhD, Christine Ta Thanh Minh, MD

Blood (2013) 122 (21): 4566.

https://doi.org/10.1182/blood.V122.21.4566.4566

Published: 2013

Journal Articles

Late Relapse in Leukemia: Does the Niche Matter?

Paolo Bernasconi, Marina Boni, Paola Maria Cavigliano, PhD, Barbara Rocca, BSc, Rita Zappatore, PhD, Irene Dambruoso, Ilaria Giardini, PhD, Celeste Calvello, BSc, Marilena Caresana, PhD, Daniela Caldera, MD, Anna Amelia Colombo, MD, Manuela Santantonio, MD, Francesco Ripamonti, MD, Emilio Paolo Alessandrino, MD

Blood (2012) 120 (21): 4793.

https://doi.org/10.1182/blood.V120.21.4793.4793

Published: 2012

NARROW

Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)

Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Polycythemia Vera or Essential Thrombocythemia Transformed to Myelofibrosis or Acute Myeloid Leukemia: a Single Center Experience

Can Allo-HSCT Improve the Poor Clinical Outcome of the “Internal Tandem Duplication” of the FLT3 Gene?

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Late Relapse in Leukemia: Does the Niche Matter?

Email alerts

ASH Publications

American Society of Hematology

Virological and Immunological Monitoring of Human Cytomegalovirus (HCMV) Infection in Hematopoietic Stem Cell Transplantation Recipients (HSCTR)

Comparing Costs Associated to Letermovir Prophylaxis Vs Ganciclovir Pre-Emptive Therapy in HCMV-Seropositive Patients Who Undergone to Hemopoietic Stem Cells Transplantation

Veno-Occlusive Disease (VOD) after Hematopoietic Stem Cell Transplant (HSCR): Always a Catastrophic Illness?

Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Polycythemia Vera or Essential Thrombocythemia Transformed to Myelofibrosis or Acute Myeloid Leukemia: a Single Center Experience

Can Allo-HSCT Improve the Poor Clinical Outcome of the “Internal Tandem Duplication” of the FLT3 Gene?

Intravenous Once-Daily BuCy 2 With Pharmacokinetic (PK)-Guided Dose Adjustment As Conditioning Regimen For AML Patients In First Complete Remission

Late Relapse in Leukemia: Does the Niche Matter?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only